Safety aspects of preoperative high-dose glucocorticoid in primary total knee replacement
Conclusions: In this detailed prospective cohort study, preoperative high-dose glucocorticoid administration was not associated with LOS>4 days, readmissions or infectious complications in TKA patients without contraindications.Clinical trial registration: NCT01515670.
Source: British Journal of Anaesthesia - Category: Anesthesiology Source Type: research
More News: Anesthesia | Anesthesiology | Clinical Trials | Databases & Libraries | Methylprednisolone | Study | UK Health